ACHC

$23.73

Post-MarketAs of Mar 17, 8:00 PM UTC

Acadia Healthcare Company, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$23.73
Potential Upside
5%
Whystock Fair Value$24.92
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.73
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-40.96%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.29

Recent News

Simply Wall St.
Mar 15, 2026

Is Acadia Healthcare (ACHC) Quietly Rewriting Its Capital Strategy With Daniel Cancelmi’s Board Appointment?

Acadia Healthcare Company has added veteran healthcare finance executive Daniel Cancelmi to its Board of Directors, following his long tenure as CFO of Tenet Healthcare and extensive experience overseeing large-scale finance operations and portfolio reshaping. This board appointment brings deep expertise in balance sheet management, large healthcare transactions, and hospital-level performance oversight, which could be particularly relevant as Acadia continues expanding its behavioral health...

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Simply Wall St.
Mar 14, 2026

New Acadia Healthcare Director Brings Finance Focus To Growth And Valuation

Acadia Healthcare Company (NasdaqGS:ACHC) has appointed Daniel Cancelmi, former Tenet Healthcare CFO, to its Board of Directors. Current director Wade D. Miquelon has informed the company that he will not stand for re election and will leave the board at the upcoming annual meeting. Acadia Healthcare, a provider of behavioral healthcare services, operates in a sector that continues to draw attention as demand for mental health and addiction treatment remains a core focus for payors,...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 10, 2026

Acadia Healthcare Highlights $200M EBITDA Upside as New Beds Ramp Amid Medicaid, Staffing Headwinds

Acadia Healthcare (NASDAQ:ACHC) CFO Todd Young discussed the company’s operational priorities, policy headwinds, and cash flow outlook during a conversation at the Barclays Global Healthcare Conference. Young, who said he has been in the CFO role for “just over 4 months,” emphasized execution and oc

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Insider Monkey
Mar 10, 2026

Barclays Retains an Equal Weight Rating on Acadia Healthcare Company, Inc. (ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is among the 12 Best Performing Stocks in February. On March 2, 2026, Barclays analyst Andrew Mok elevated Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s price goal to $20 from $14, maintaining an Equal Weight rating. On February 25, 2026, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced fourth-quarter 2025 revenue of $821.5 million, […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 9, 2026

Acadia Healthcare CFO Details 2026 Focus: Bed Ramp-Ups, Medicaid Headwinds, and Malpractice Costs

Acadia Healthcare (NASDAQ:ACHC) Chief Financial Officer Todd Young, who joined the company about four months ago, outlined management’s focus areas for 2026 during a conference discussion that touched on facility ramp-ups, organizational changes, payer dynamics, and litigation and malpractice costs.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.